ScholarIQanswers from OpenAlex

Opioid agonist treatment in transition: A cross-country comparison between Austria, Germany and Switzerland

PaperCitations, authors & open-access status

Opioid agonist treatment in transition: A cross-country comparison between Austria, Germany and Switzerland is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Opioid agonist treatment in transition: A cross-country comparison between Austria, Germany and Switzerland have?

ScholarIQcitation count

Opioid agonist treatment in transition: A cross-country comparison between Austria, Germany and Switzerland has 13 citations in the OpenAlex counts ScholarIQ stores.

When was Opioid agonist treatment in transition: A cross-country comparison between Austria, Germany and Switzerland published?

ScholarIQyear

Opioid agonist treatment in transition: A cross-country comparison between Austria, Germany and Switzerland has 2023 year in the ScholarIQ index.

What is the open-access status of Opioid agonist treatment in transition: A cross-country comparison between Austria, Germany and Switzerland?

ScholarIQoa status

Opioid agonist treatment in transition: A cross-country comparison between Austria, Germany and Switzerland has hybrid oa status in the ScholarIQ index.

What is the DOI of Opioid agonist treatment in transition: A cross-country comparison between Austria, Germany and Switzerland?

ScholarIQdoi

The DOI for Opioid agonist treatment in transition: A cross-country comparison between Austria, Germany and Switzerland is on the source record.

What is the PMID of Opioid agonist treatment in transition: A cross-country comparison between Austria, Germany and Switzerland?

ScholarIQpmid

The PMID for Opioid agonist treatment in transition: A cross-country comparison between Austria, Germany and Switzerland is on the source record.

What is the OpenAlex record for Opioid agonist treatment in transition: A cross-country comparison between Austria, Germany and Switzerland?

ScholarIQopenalex

The OpenAlex for Opioid agonist treatment in transition: A cross-country comparison between Austria, Germany and Switzerland is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial